Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults
Clinical trial NCT03766724 · COMPLETED
Trial details
- NCT number
- NCT03766724
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-22
- Primary completion
- 2019-01-18
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.